Hansen Medical Announces Filing For The Registration of Securities That Were Previously Sold In Private Placement Transactions

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, CA--(Marketwired - November 11, 2013) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, announced the November 8, 2013 filing of two separate registration statements on Form S-3 to register previously issued shares, and shares issuable upon the exercise of previously issued warrants. The previously issued shares and warrants were sold by the Company in separate private placement transactions in November 2012 and August 2013. No new shares were issued by the Company with the filing of the two Form S-3 registration statements. While the Company is contractually obligated to file the registration statements, any potential transactions under these registration statements are subject both to contractual lockup periods -- expiring April 2014 and August 2014, respectively, -- and the effectiveness of the respective registration statements.

Hansen Medical, Heart Design (Logo), and Hansen Medical (with Heart Design) are registered trademarks of Hansen Medical, Inc. in the United States and other countries.


Investor Contacts:
Peter J. Mariani
Chief Financial Officer
Hansen Medical, Inc.
650.404.5800

FTI Consulting, Inc.
Brian Ritchie
212.850.5683
Email Contact

John Capodanno
212.850.5705
Email Contact



Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC